Hakutulokset - Kurt Cooper

  • Näytetään 1 - 3 yhteensä 3 tuloksesta
Tarkenna hakua
  1. 1
    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever

    Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever Tekijä Tiago Abreu-Mota, Katie R. Hagen, Kurt Cooper, Peter B. Jahrling, Gene S. Tan, Christoph Wirblich, Reed F. Johnson, Matthias J. Schnell

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models

    An Inactivated Rabies Virus–Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Model... Tekijä Reed F. Johnson, Drishya Kurup, Katie R. Hagen, Christine R. Fisher, Rohan Keshwara, Amy B. Papaneri, Donna L. Perry, Kurt Cooper, Peter B. Jahrling, Jonathan T. Wang, Jan ter Meulen, Christoph Wirblich, Matthias J. Schnell

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

    A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene Tekijä Yíngyún Caì, Chengjin Ye, Benson Yee Hin Cheng, Aitor Nogales, Masaharu Iwasaki, Shuǐqìng Yú, Kurt Cooper, David X. Liu, Randy Hart, Ricky Adams, Tyler Brady, Elena Postnikova, Jonathan Kurtz, Marisa St. Claire, Jens H. Kuhn, Juan Carlos de la Torre, Luis Martínez‐Sobrido

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: